Entera Bio Ltd
NASDAQ:ENTX
Entera Bio Ltd
Interest Income Expense
Entera Bio Ltd
Interest Income Expense Peer Comparison
Competitive Interest Income Expense Analysis
Latest Figures & CAGR of Competitors
Company | Interest Income Expense | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Entera Bio Ltd
NASDAQ:ENTX
|
Interest Income Expense
$31k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-43%
|
CAGR 10-Years
N/A
|
|
Collplant Biotechnologies Ltd
NASDAQ:CLGN
|
Interest Income Expense
$503k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Kamada Ltd
NASDAQ:KMDA
|
Interest Income Expense
-$655k
|
CAGR 3-Years
6%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
15%
|
|
B
|
BioLine RX Ltd
TASE:BLRX
|
Interest Income Expense
-$101k
|
CAGR 3-Years
58%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
22%
|
Urogen Pharma Ltd
NASDAQ:URGN
|
Interest Income Expense
-$12.1m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
B
|
Bonus Biogroup Ltd
TASE:BONS
|
Interest Income Expense
₪1.9m
|
CAGR 3-Years
7%
|
CAGR 5-Years
61%
|
CAGR 10-Years
N/A
|
See Also
What is Entera Bio Ltd's Interest Income Expense?
Interest Income Expense
31k
USD
Based on the financial report for Dec 31, 2023, Entera Bio Ltd's Interest Income Expense amounts to 31k USD.
What is Entera Bio Ltd's Interest Income Expense growth rate?
Interest Income Expense CAGR 5Y
-43%
Over the last year, the Interest Income Expense growth was -61%.